We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Research Highlights.
- Authors
Aschheim, Kathy; Cervoni, Nadia; DeFrancesco, Laura; Taroncher-Oldenburg, Gaspar; Zipkin, Mark
- Abstract
The article focuses on various studies related to biotechnology. As pharmacological strategies become more complex, technologies that can deliver multiple compounds with fine temporal and spatial control are expected to improve clinical outcomes. A case in point is cancer treatments that combine antiangiogenesis drugs and conventional cytotoxic drugs. New-variant Creutzfeldt-Jakob disease, a prion disease caused by consumption of meat from cows afflicted with 'mad-cow disease' or bovine spongiform encephalopathy, is readily detected in post mortem brain sections, but diagnosis from blood samples is not yet possible. Identifying the genes that orchestrate tumor growth is a priority of cancer research. Researchers have developed a screening method for discovering oncogenes and their targets using libraries of artificial zinc-finger transcription factors.
- Subjects
BIOTECHNOLOGY research; CREUTZFELDT-Jakob disease; CANCER treatment; DIAGNOSIS; PHARMACOLOGY; TRANSCRIPTION factors
- Publication
Nature Biotechnology, 2005, Vol 23, Issue 9, p1093
- ISSN
1087-0156
- Publication type
Article
- DOI
10.1038/nbt0905-1093